Nexkem Pharmaceuticals Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Orivog GM 2mg/500mg/0.3mg Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Orivog GM 2mg/500mg/0.3mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Orivog GM 2mg/500mg/0.3mg Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Orivog GM 2mg/500mg/0.3mg Tablet SR.
Orivog GM 2mg/500mg/0.3mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Orivog GM 2mg/500mg/0.3mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Orivog GM 2mg/500mg/0.3mg Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Orivog GM 2mg/500mg/0.3mg Tablet SR is a combination of Glimepiride, Metformin and Voglibose medicines used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when combined with proper diet and exercise. Glimepiride increases insulin release from the pancreas, Metformin decreases glucose production by the liver and improves insulin sensitivity, while Voglibose acts as an alpha-glucosidase inhibitor lowering postprandial glucose after meals.
Common side effects associated with using Orivog GM 2mg/500mg/0.3mg Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infections.
Orivog GM 2mg/500mg/0.3mg Tablet SR is not suitable for individuals with known allergies to its components or excipients. It's also advised against using this medication in patients with moderate to severe kidney disease and inflammatory bowel diseases, including colonic ulcers and underlying metabolic acidosis like diabetic ketoacidosis.
No, alcohol consumption should be avoided when using OriVog GM 2mg/500mg/0.3mg Tablet SR as this can lower blood sugar levels and increase the risk of lactic acidosis.
Yes, OriVog GM 2mg/500mg/0.3mg Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It's more likely to happen if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications together with it. Regular blood sugar monitoring is necessary.
Keep this medication in its original packaging, tightly closed. Store it according to the instructions on the label or pack. Dispose of any unused medicine properly and ensure pets, children, and other individuals do not access it.